Did you mean: Unimed Pharmaceuticals, LLC ?

www.unimedpharma.eu

Contact us. E-mail: unimedpharma@unimedpharma.sk. Telephone: +421 2 4333 3786. Address. UNIMED PHARMA, spol. s r.o., P.O.BOX 54, 830 00 Bratislava, ...

universalmarinemedical.com/about

Sep 19, 2017 ... Founded in 1976, Unimed is one of the oldest and largest suppliers of pharmaceutical and medical supplies to the global maritime industry.

www.thepharmaletter.com/article/solvay-group-agrees-to-acquire-unimed-pharmaceuticals-for-123-million

Belgium's Solvay says that its US unit is to acquire all outstandingshares of Unimed Pharmaceuticals, based in Buffalo, Illinois. Solvay Pharmaceuticals has  ...

www.linkedin.com/company/unimed-international-ltd

Learn about working at Unimed International Ltd. Join LinkedIn today for free. See who you know at Unimed ... Pharmaceuticals24 followers. Vika Nachkebia ...

www.centerwatch.com/drug-information/fda-approved-drugs/drugs/company/Unimed+Pharmaceuticals

Organized by drug name, this comprehensive listing of FDA-Approved Drugs by the Food and Drug Administration features facts on clinical trial results, side ...

www.ftc.gov/system/files/documents/cases/140908abbviecmpt1.pdf

Sep 26, 2014 ... Unimed Pharmaceuticals, LLC (collectively, "AbbVie Defendants"), Besins Healthcare, Inc., and Teva Pharmaceuticals USA, Inc., to undo and ...

biopharmguy.com/links/company-by-name-defunct.php

3-Dimensional Pharmaceuticals, Acquired by J&J, Jan 2003, $88M. Add'l Locations ... Aarden Pharmaceuticals, Confirmed gone by co-founder ..... Akesis LLC, Bankrupt 2015 ...... Unimed Pharmaceuticals Inc, Acquired by Solvay June 1999.

healtheconomics.global-summit.com/speaker/2018/guilherme-santos-crespo-unimed-vit-ria-brazil

Jul 27, 2018 ... Guilherme Santos Crespo from Unimed Vitória | Brazil is a speaker at ... Global Conference Series LLC LTD Events with over 1000+ Conferences, ... on Medical, Pharma, Engineering, Science, Technology and Business.

www.sunpharma.com

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by ...